This website uses cookies to ensure you get the best experience on our website.

Amferia and selected partners use cookies and similar technologies to ensure you get the best experience on this website. If you consent to it, we will use cookies for analytics and marketing purposes.

See our Cookie Policy to read more about the cookies we set.

You can withdraw and manage your consent at any time, by clicking "Manage cookies" at the bottom of each website page.

Select which cookies you accept

On this site, we always set cookies that are strictly necessary, meaning they are necessary for the site to function properly.

If you consent to it, we will also set other types of cookies. You can provide or withdraw your consent to the different types of cookies using the toggles below. You can change or withdraw your consent at any time, by clicking the link “Manage Cookies”, which is always available at the bottom of the site.

To learn more about what the different types of cookies do, how your data is used when they are set etc, see our Cookie Policy.

These cookies are necessary to make the site work properly, and are always set when you visit the site.

Vendors Teamtailor

These cookies collect information to help us understand how the site is being used.

Vendors Teamtailor

These cookies are used to make advertising messages more relevant to you. In some cases, they also deliver additional functions on the site.

Vendors Youtube
Amferia career site

Join us in this exciting journey!

Connect

Welcome to Amferia

Amferia is a young and fast growing medical-device company founded on an innovative new antimicrobial technology that aims to address the global threat of antibiotic resistance (ABR). Over the past 3 years, Amferia has translated basic research to product development for human and veterinary wound care – a one-health approach to fight ABR. In 2021, Amferia is working towards the launch of our first product – a rapid antimicrobial wound patch for veterinary use in Europe while also filing for CE marking of our first human wound dressing. The prestigious scientific journal Nature named Amferia as ‘one-to-watch’ - among top 44 pioneering start-ups worldwide with outstanding scientific groundwork. 

 

How we work

You will be part of a fast-growing  company that has the vision of fighting one of the pressing global health challenges of the world. Amferia's foundation comes from fundamental research which has instilled a culture of pursuing good science, evidence based approach, critical thinking and of asking good questions. We welcome talented individuals to join us on this exciting journey to learn as well as translate good science to impactful products for patients around the world. 

Gothenburg (Mölndal)

About Amferia

Amferia was founded in 2018 and develops new antimicrobial materials for use in medical devices. The technology is based on bioinspired and amphiphilic antibacterial polymers that target and rapidly kill bacteria upon contact, including numerous antibiotic resistant bacteria like MRSA and MDR E. Coli. The material is highly selective and targets only bacteria while being entirely non-toxic to animal and human cells. Today, Amferia has transformed this concept into a first product of a preventive wound care patch for skin wound applications supported by strong scientific data and publications. 

Founded in 2018
Co-workers 7

Already working at Amferia?

Let’s recruit together and find your next colleague.

@amferia.com